Cell adhesion signaling pathways: First responders to cocaine exposure?

Communicative and Integrative Biology

Volumn 4, Issue 1, 2011, Pages 1-4

  Gourley, Shannon L ^a,b   Taylor, Jane R ^a,b   Koleske, Anthony J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Abl; Addiction; Cocaine; Dopamine; Integrin; Orbitofrontal; Psychostimulant; Striatum

Indexed keywords

RODENTIA;

EID: 79951719984     PISSN: None     EISSN: 19420889     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Bradley WD, Koleske AJ. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts. J Cell Sci 2009; 122:3441-54.
2. Hernández SE, Settleman J, Koleske AJ. Adhesion-dependent regulation of p190RhoGAP in the developing brain by the Abl-related gene tyrosine kinase. Curr Biol 2004; 14:691-6.
3. Moresco EMY, Donaldson S, Williamson A, Kolese AJ. Integrin-mediated dendrite branch maintenance requires abelson (Abl) family kinases. J Neurosci 2005; 25:6105-18.
4. Bradley WD, Hernández SE, Settleman J, Koleske AJ. Integrin signaling through Arg activates p190RhoGAP by promoting its binding to p120Ras-GAP and recruitment to the membrane. Mol Biol Cell 2006; 17:4827-36.
5. Sfakianos MK, Eisman A, Gourley SL, Bradley WD, Scheetz AJ, Settleman J, et al. Inhibition of Rho via Arg and p190RhoGAP in the postnatal mouse hippocampus regulates dendritic spine maturation, synapse and dendrite stability and behavior. J Neurosci 2007; 27:10982-92.
6. Ruchhoeft ML, Ohnuma S, McNeill L, Holt CE, Harris WA. The neuronal architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases in vivo. J Neurosci 1999; 19:8454-63.
7. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24:417-63.
8. Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997; 17:8491-7.
9. Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004; 47:33-46.
10. Shen HW, Toda S, Moussawi K, Bouknight A, Zahm DS, Kalivas PW Altered dendritic spine plasticity in cocaine-withdrawn rats. J Neurosci 2009; 29:2876-84.
11. Pollard TD. Regulation of actin filament assembly by Arp2/3 complex and formins. Annu Rev Biophys Biomol Struct 2007; 36:451-77.
12. Toda S, Shen HW, Peters J, Cagle S, Kalivas PW Cocaine increases actin cycling: effects in the reinstatement model of drug seeking. J Neurosci 2006; 26:1579-87.
13. Pulipparacharuvil S, Renthal W, Hale CF, Taniguchi M, Xiao G, Kumar A, et al. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 2008; 59:621-33.
14. Kiraly DD, Ma XM, Mazzone CM, Xin X, Mains RE, Eipper BA. Behavioral and morphological responses to cocaine require kalirin7. Biol Psychiatry 2010; 68:249-55.
15. Chandler LJ, Kalivas PW. Brain's defence against cocaine. Nature 2008; 455:743-4.
16. Gourley SL, Koleske AJ, Taylor JR. Loss of dendrite stabilization by the Abl-related gene (Arg) kinase regulates behavioral flexibility and sensitivity to cocaine. Proc Natl Acad Sci USA 2009; 106:16859-64.
17. Taylor JR, Robbins TW Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology 1984; 84:405-12.
18. Taylor JR, Horger BA. Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization. Psychopharmacology (Berl) 1999; 142:31-40.
19. Taylor JR, Jentsch JD. Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: differential effects of cocaine, d-amphetamine and 3,4-methylenedioxymethamphetamine ("Ecstasy"). Biol Psychiatry 2001; 50:137-43.
20. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000; 95:91-117.
21. Wiggins AT, Pacchioni AM, Kalivas PW Integrin expression is altered after acute and chronic cocaine. Neurosci Lett 2009; 450:321-3.
22. Kim WY, Shin SR, Kim S, Jeon S, Kim JH. Cocaine regulates ezrin-radixin-moesin proteins and RhoA signaling in the nucleus accumbens. Neuroscience 2009; 163:501-5.
23. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001; 410:376-80.
24. Taylor JR, Lynch WJ, Sanchez H, Olausson P, Nestler EJ, Bibb JA. Inhibition of Cdk5 in the nucleus accumbens enhances the locomotor-activating and incentive-motivational effects of cocaine. Proc Natl Acad Sci USA 2007; 104:4147-52.
25. Benavides DR, Quinn JJ, Zhong P, Hawasli AH, DiLeone RJ, Kansy JW, et al. Cdk5 modulates cocaine reward, motivation and striatal neuron excitability. J Neurosci 2007; 27:12967-76.
26. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003; 116:19-22.
27. Tripathi BK, Zelenka PS. Cdk5-dependent regulation of Rho activity, cytoskeletal contraction and epithelial cell migration via suppression of Src and p190RhoGAP Mol Cell Biol 2009; 29:6488-99.
28. Crombag HS, Gorny G, Li Y, Kolb B, Robinson PV. Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 2004; 15:341-8.
29. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, et al. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11:184-90.
30. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14:169-77.
31. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10:318-25.
32. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158:2015-21.
33. Rogers RD, Robbins TW. Investigating the neurocog-nitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001; 11:250-7.
34. Porrino LJ, Lyons D, Miller MD, Smith HR, Friedman DP, Daunais JB, et al. Metabolic mapping of the effects of cocaine during the initial phases of self-administration in the nonhuman primate. J Neurosci 2002; 22:7687-94.
35. Beveridge TJ, Smith HR, Daunais JB, Nader MA, Porrino LJ. Chronic cocaine self-administration is associated with altered functional activity in the temporal lobes of non human primates. Eur J Neurosci 2006; 23:3109-18.
36. Lyons D, Friedman DP, Nader MA, Porrino LJ. Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci 1996; 16:1230-8.
37. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology 1999; 146:373-90.
38. Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature 1999; 398:567-70.
39. Gourley SL, Lee AS, Howell JL, Pittenger C, Taylor JR. Dissociable regulation of goal-directed action within mouse prefrontal cortex. Eur J Neurosci 2010; 32:1726-34.
40. Jentsch JD, Olausson P, De La Garza R, 2nd, Taylor JR. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 2002; 26:183-90.
41. Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B. Cocaine-experienced rats exhibit learning deficits in a task sensitive to orbitofrontal cortex lesions. Eur J Neurosci 2004; 19:1997-2002.
42. Calu DJ, Stalnaker TA, Franz TM, Singh T, Shaham Y, Schoenbaum G. Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats. Learn Mem 2007; 14:325-8.
43. Horch HW, Krüttgen A, Portbury ST, Katz LC. Destabilization of cortical dendrites and spines by BDNF. Neuron 1999; 23:353-64.
44. Horch HW, Katz LC. BDNF released from single cells elicits local dendritic growth in nearby neurons. Nat Neurosci 2002; 5:1177-84.
45. Xu B, Zang K, Ruff NL, Zhang YA, McConnell SK, Stryker MP, et al. Cortical degeneration in the absence of neurotrophin signaling: Dendritic retraction and neuronal loss after removal of the receptor trkB. Neuron 2000; 26:233-45.
46. Gorski JA, Zeiler SR, Tamowski S, Jones KR. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 2003; 23:6856-65.
47. Couch BA, DeMarco GJ, Gourley SL, Koleske AJ. Increased dendrite branching in AβPP/PS1 mice and elongation of dendrite arbors by fasudil administration. J Alzheimers Dis 2010; 20:1003-8.
48. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, et al. Effect of AT877 on cerebral vaso-spasm after aneurysmal subarachnoid hemorrhage. "Results of a prospective placebo-controlled double-blind trial. J Neurosurg 1992; 76:571-7.
49. Kernie SG, Liebl DJ, Parada LF BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000; 19:1290-300.
50. Gourley SL, Howell JL, Rios M, DiLeone RJ, Taylor JR. Prelimbic cortex bdnf knock-down reduces instrumental responding in extinction. Learn Mem 2009; 16:756-60.
51. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997; 389:856-60.
52. Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, Wiese S, et al. Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 2010; 30:1739-49.
53. Lobo MK, Covington HE, Chaudhury D, Friedman AK, Sun H, Damez-Werno D, et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010; 330:385-90.
54. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999; 19:4110-22.
55. Homayoun H, Moghaddam B. Orbitofrontal cortex neurons as a common target for classic and glutamater-gic antipsychotic drugs. Proc Natl Acad Sci USA 2008; 105:18041-6.
56. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003; 160:1041-52.